TP53 and pancreatic adenocarcinoma: Conversely, high expression of RAB7A was associated with the regulation of TP53 activity, the pancreatic adenocarcinoma pathway, pancreatic cancer, the regulation of RAS by gaps, and oncogenic MAPK signalling.